Common Sense Oncology: including everyone.
作者信息
Ergun Yakup
机构信息
Department of Medical Oncology, Batman World Hospital, Batman 07200, Turkey.
出版信息
Lancet Oncol. 2023 Oct;24(10):e403. doi: 10.1016/S1470-2045(23)00359-5.
Abstract
摘要
相似文献
1
Common Sense Oncology: including everyone.常识肿瘤学：涵盖每一个人。
Lancet Oncol. 2023 Oct;24(10):e403. doi: 10.1016/S1470-2045(23)00359-5.
2
Common Sense Oncology: including everyone.常识肿瘤学：涵盖所有人。
Lancet Oncol. 2023 Oct;24(10):e402. doi: 10.1016/S1470-2045(23)00413-8.
3
Common Sense Oncology: including everyone - Authors' reply.《肿瘤学常识：涵盖所有人》——作者回复
Lancet Oncol. 2023 Oct;24(10):e404. doi: 10.1016/S1470-2045(23)00464-3.
4
Challenges of creating a one-size-fits-all oncology CPOE application.创建一个适用于所有情况的肿瘤学计算机化医师医嘱录入（CPOE）应用程序所面临的挑战。
Stud Health Technol Inform. 2006;122:902.
5
Common Sense Oncology: outcomes that matter.《肿瘤学常识：重要的结局》
Lancet Oncol. 2023 Aug;24(8):833-835. doi: 10.1016/S1470-2045(23)00319-4. Epub 2023 Jul 16.
6
Cancer treatments should benefit patients: a common-sense revolution in oncology.癌症治疗应使患者受益：肿瘤学的一场常识性变革。
Nat Med. 2022 Apr;28(4):617-620. doi: 10.1038/s41591-021-01662-6.
7
Common Sense Oncology: Equity, Value, and Outcomes That Matter.《肿瘤常识》：公平、价值和重要的结局。
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100039. doi: 10.1200/EDBK_100039.
8
Regulating hematology/oncology research involving human participants.规范涉及人类受试者的血液学/肿瘤学研究。
Hematol Oncol Clin North Am. 2002 Dec;16(6):1449-61. doi: 10.1016/s0889-8588(02)00067-9.
9
To Address Burnout in Oncology, We Must Look to Teams: Reflections on an Organizational Science Approach.要解决肿瘤学中的倦怠问题，我们必须着眼于团队：对组织科学方法的思考。
JCO Oncol Pract. 2020 Apr;16(4):e377-e383. doi: 10.1200/JOP.19.00631. Epub 2020 Feb 19.
10
Why do we need a core curriculum in surgical oncology in Europe?为何我们欧洲需要外科肿瘤学核心课程？
Surg Oncol. 2008 Dec;17(4):267-9. doi: 10.1016/j.suronc.2008.06.001. Epub 2008 Jul 21.
引用本文的文献
1
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.应对遗传性肿瘤异质性、治疗后转移扩散、癌症再增殖以及获得性肿瘤细胞耐药性的发展。
Cancers (Basel). 2023 Dec 29;16(1):180. doi: 10.3390/cancers16010180.
Zotero 插件